SubHero Banner
Text

August 2022

Core topics in this month’s edition include:

  • Zynteglo (betibeglogene autotemcel) – new drug approval
  • Cimerli (ranibizumab-eqrn) – new biosimilar approval
  • Xenpozyme (olipudase alfa-rpcp) – new drug approval

Download PDF

Text